Statistics for Hikma Pharmaceuticals PLC (id:3285 HIK)

Valuation metrics

Market cap

4.15B

Enterprise value

4.11B

Trailing P/E (ttm)

27.94

Forward P/E

10.52

PEG ratio

10.52

Price/Sales (ttm)

1.38

Price/Book (mrq)

181.59

Enterprise Value/Revenue

1.72

Enterprise Value/EBITDA

6.14

Overview

Shares outstanding

221.88M

Float

155.33M

Shares short

% Held by insiders

0.31%

% Held by institutions

0.42%

Average volume (10 days)

441.98K

Average volume (90 days)

Price summary

52-Week low

1.71K

52-Week high

2.16K

52-Week change

9.85%

Beta

0.44

50-Day moving average

1.90K

200-Day moving average

1.92K

Dividends and splits

Forward annual dividend rate

128.00

Forward annual dividend yield

0.07

Trailing annual dividend rate

0.79%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

1.99

Payout ratio

0.73

Dividend date

Ex-dividend date

August 15th, 2024

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

9.45%

Operating margin

25.62%

Operational effectiveness

Return on assets

9.40%

Return on equity

12.88%

Income statement

Revenue (ttm)

13.68

Revenue per share (ttm)

13.68

Quarterly revenue growth (yoy)

0.72

Gross profit (ttm)

1.39B

EBITDA

786.00M

Net income to common (ttm)

226.36M

Diluted EPS (ttm)

0.67

Quarterly earnings growth (yoy)

72.50%

Balance sheet

Total cash (mrq)

206.50M

Total cash per share (mrq)

1.17

Total debt (mrq)

1.01B

Total Debt/Equity (mrq)

55.48

Current ratio (mrq)

165.60%

Book value per share (mrq)

10.31

Cash flow

Cash flow statement

463.83M

Levered free cash flow (LFCF)

325.93M